Abstract
Primary vaginal cancer is a rare entity representing about 2% of all female genital neoplasias and only 0.1–0.2% of all cancers (Jemal et al. 59(4):225–249, 2009). Most carcinomas found in the vagina represent direct extension or metastasis from other primary gynecologic (cervix or vulva) and non-gynecologic sites, most commonly breast and gastrointestinal tract. There are a number of controversies in terms of epidemiology, staging, and diagnostic evaluation as well as in the management of vaginal cancer. Because of its rarity, there is a lack of prospective, randomized studies in patients with vaginal cancer, and therefore it is difficult to establish strong, evidence based-recommendations. Decisions regarding therapeutic options are for the most part, based on retrospective data and individual assessment using general principles derived from clinical experience in the cancer management in other sites. Most of the available data refer to the treatment of primary invasive SCC of the vagina, since this represents the most common histology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aho M, Vesterinen E, Meyer B, Purola E, Paavonen J (1991) Natural history of vaginal intraepithelial neoplasia. Cancer 68(1):195–197
Aktas M, de Jong D, Nuyttens JJ, van der Zee J, Wielheesen DH, Batman E, Burger CW, Ansink AC (2007) Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study. Eur J Obstet Gynecol Reprod Biol 133(1):100–104. doi:10.1016/j.ejogrb.2006.05.005
Ali MM, Huang DT, Goplerud DR, Howells R, Lu JD (1996) Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor. Cancer 77(9):1934–1939. doi:10.1002/(SICI)1097-0142(19960501)77:9<1934::AID-CNCR25>3.0.CO;2
Al-Kurdi M, Monaghan JM (1981) Thirty-two years experience in management of primary tumours of the vagina. Br J Obstet Gynaecol 88(11):1145–1150
American Joint Committee on Cancer (2010) Vagina. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti III A (eds) AJCC Cancer Staging Manual, 7th edn. Springer, New York, pp 469–472
Antonioli DA, Burke L (1975) Vaginal adenosis. Analysis of 325 biopsy specimens from 100 patients. Am J Clin Pathol 64(5):625–638
Au SP, Grigsby PW (2003) The irradiation tolerance dose of the proximal vagina. Radiother Oncol 67(1):77–85. S0167814002003845[pii]
Ball HG, Berman ML (1982) Management of primary vaginal carcinoma. Gynecol Oncol 14(2):154–163. 0090-8258(82)90085-3[pii]
Benedetti Panici P, Bellati F, Plotti F, Di Donato V, Antonilli M, Perniola G, Manci N, Muzii L, Angioli R (2008) Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma. Gynecol Oncol 111(2):307–311. doi: 10.1016/j.ygyno.2008.07.005
Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP (2006) High-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy 5(4):218–222. doi:10.1016/j.brachy.2006.09.002
Beriwal S, Heron DE, Mogus R, Edwards RP, Kelley JL, Sukumvanich P (2008) High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina. Radiat Oncol 3:7. doi:10.1186/1748-717X-3-7
Boonlikit S, Noinual N (2010) Vaginal intraepithelial neoplasia: a retrospective analysis of clinical features and colpohistology. J Obstet Gynaecol Res 36(1):94–100. doi:10.1111/j.1447-0756.2009.01108.x
Brabham JG, Cardenes HR (2009) Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience. Am J Clin Oncol 32(4):417–422. doi:10.1097/COC.0b013e318191bfc7
Brinton LA, Nasca PC, Mallin K, Schairer C, Rosenthal J, Rothenberg R, Yordan E Jr, Richart RM (1990) Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 38(1):49–54. 0090-8258(90)90010-I[pii]
Cardenes H, Song G, Randall M (2001) Late sequelae of radiation therapy in the management of gynecological malignancies. Current medical literature. Gynecol Oncol 2:1–10
Chang YC, Hricak H, Thurnher S, Lacey CG (1988) Vagina: evaluation with MR imaging. Part II. Neoplasms. Radiology 169(1):175–179
Charra C, Roy P, Coquard R, Romestaing P, Ardiet JM, Gerard JP (1998) Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy. Int J Radiat Oncol Biol Phys 40(2):421–426. S0360301697005762[pii]
Childers JM, Surwit EA (1993) Current status of operative laparoscopy in gynecologic oncology. Oncology (Williston Park) 7(11):47–51 discussion 53-44, 57
Chu AM, Beechinor R (1984) Survival and recurrence patterns in the radiation treatment of carcinoma of the vagina. Gynecol Oncol 19(3):298–307
Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35(5):891–905. doi:10.1016/0360-3016(95)02394-1
Corn BW, Lanciano RM, Rosenblum N, Schnall M, King S, Epperson R (1995) Improved treatment planning for the Syed-Neblett template using endorectal-coil magnetic resonance and intraoperative (laparotomy/laparoscopy) guidance: a new integrated technique for hysterectomized women with vaginal tumors. Gynecol Oncol 56(2):255–261. doi:10.1006/gyno.1995.1042
Creasman WT, Phillips JL, Menck HR (1998) The National Cancer Data Base report on cancer of the vagina. Cancer 83(5):1033–1040. doi:10.1002/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.0.CO;2-6
Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84(2):263–270. doi:10.1006/gyno.2001.6502
Dalrymple JL, Russell AH, Lee SW, Scudder SA, Leiserowitz GS, Kinney WK, Smith LH (2004) Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 14(1):110–117. 14066[pii]
Dancuart F, Delclos L, Wharton JT, Silva EG (1988) Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failures analysis–the M. D. Anderson Hospital experience 1955–1982. Int J Radiat Oncol Biol Phys 14(4):745–749
Davis KP, Stanhope CR, Garton GR, Atkinson EJ, O’Brien PC (1991) Invasive vaginal carcinoma: analysis of early-stage disease. Gynecol Oncol 42(2):131–136
de Crevoisier R, Sanfilippo N, Gerbaulet A, Morice P, Pomel C, Castaigne D, Pautier P, Lhomme C, Duvillard P, Haie-meder C (2007) Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol 85(3):362–370. doi:10.1016/j.radonc.2007.09.015
Delanian S, Porcher R, Balla-Mekias S, Lefaix JL (2003) Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21(13):2545–2550. doi:10.1200/JCO.2003.06.064
Delclos L (1984) Technical basis of radiation therapy practical clinical applications. Lea & Febiger, Philadelphia
Delclos L, Fletcher GH, Moore EB, Sampiere VA (1980) Minicolpostats, dome cylinders, other additions and improvements of the Fletcher-suit afterloadable system: indications and limitations of their use. Int J Radiat Oncol Biol Phys 6(9):1195–1206
Deodato F, Macchia G, Grimaldi L, Ferrandina G, Lorusso D, Salutari V, Cilla S, Valentini V, Cellini N, Piermattei A, Scambia G, Morganti AG (2009) Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep 22(2):415–419
Diakomanolis E, Rodolakis A, Boulgaris Z, Blachos G, Michalas S (2002) Treatment of vaginal intraepithelial neoplasia with laser ablation and upper vaginectomy. Gynecol Obstet Invest 54(1):17–20. goi54017[pii]
Disaia PJ, Syed N, Puthawala AA (1990) Malignant neoplasia of the upper vagina. Endocurietherapy/Hyperthermia Oncol 6:251–256
Dittmer PH, Randall ME (2001) A technique for inguinal node boost using photon fields defined by asymmetric collimator jaws. Radiother Oncol 59(1):61–64. S0167814000002279[pii]
Dixit S, Singhal S, Baboo HA (1993) Squamous cell carcinoma of the vagina: a review of 70 cases. Gynecol Oncol 48(1):80–87. doi:10.1006/gyno.1993.1013
Ebrahim S, Daponte A, Smith TH, Tiltman A, Guidozzi F (2001) Primary mucinous adenocarcinoma of the vagina. Gynecol Oncol 80(1):89–92. doi:10.1006/gyno.2000.5963
Eddy GL, Marks RD Jr, Miller MC 3rd, Underwood PB Jr (1991) Primary invasive vaginal carcinoma. Am J Obstet Gynecol 165(2):292–296. 0002-9378(91)90081-2[pii] discussion 296–298
Epstein JA, Sung R, Wang JC (2001) Re: correlation between a positive Hoffmann’s reflex and cervical pathology in asymptomatic individuals. Spine (Phila Pa 1976) 26(14):1639–1640
Evans LS, Kersh CR, Constable WC, Taylor PT (1988) Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies. Int J Radiat Oncol Biol Phys 15(4):901–906
Fanning J, Manahan KJ, McLean SA (1999) Loop electrosurgical excision procedure for partial upper vaginectomy. Am J Obstet Gynecol 181(6):1382–1385. S0002937899007425[pii]
FIGO Committee on Gynecologic Oncology (2009) Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynecol Obstet 105(1):3–4
Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, Warlam-Rodenhuis CC, Jobsen JJ, van Rhoon GC, van der Zee J (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70(4):1176–1182. doi:10.1016/j.ijrobp.2007.07.2348
Frank SJ, Jhingran A, Levenback C, Eifel PJ (2005) Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62(1):138–147. doi:10.1016/j.ijrobp.2004.09.032
Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ (2007) Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470–474. doi:10.1016/j.ygyno.2007.01.005
Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF (2008) Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108(3):478–481. doi:10.1016/j.ygyno.2007.12.001
Gallup DG, Castle CA, Stock RJ (1987a) Recurrent carcinoma in situ of the vagina following split-thickness skin graft vaginoplasty. Gynecol Oncol 26(1):98–102
Gallup DG, Talledo OE, Shah KJ, Hayes C (1987b) Invasive squamous cell carcinoma of the vagina: a 14-year study. Obstet Gynecol 69(5):782–785
Garton GR, Gunderson LL, Webb MJ, Wilson TO, Cha SS, Podratz KC (1997) Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution. Int J Radiat Oncol Biol Phys 37(4):839–843. S0360-3016(96)00546-9[pii]
Gemignani ML, Alektiar KM, Leitao M, Mychalczak B, Chi D, Venkatraman E, Barakat RR, Curtin JP (2001) Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int J Radiat Oncol Biol Phys 50(3):687–694. S0360-3016(01)01507-3[pii]
Gore E, Gillin MT, Albano K, Erickson B (1995) Comparison of high dose-rate and low dose-rate dose distributions for vaginal cylinders. Int J Radiat Oncol Biol Phys 31(1):165–170. 036030169400326G[pii]
Grigsby PW, Russell A, Bruner D, Eifel P, Koh WJ, Spanos W, Stetz J, Stitt JA, Sullivan J (1995) Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys 31(5):1281–1299. 036030169400426L[pii]
Guckenberger M, Bachmann J, Wulf J, Mueller G, Krieger T, Baier K, Richter A, Wilbert J, Flentje M (2010) Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiother Oncol 94(1):53–59. doi:10.1016/j.radonc.2009.12.004
Gupta AK, Vicini FA, Frazier AJ, Barth-Jones DC, Edmundson GK, Mele E, Gustafson GS, Martinez AA (1999) Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. Int J Radiat Oncol Biol Phys 43(5):1055–1060. S0360-3016(98)00522-7[pii]
Haddock MG, Martinez-Monge R, Petersen IA, Wilson TO (1999) Locally advanced primary and recurrent gynecologic malignancies. EBRT with or without IORT or HDR-IORT. In: Gunderson LL, Willet CG BHL, Calvo FA (eds) Intraoperative Irradiation: Techniques and Results. Current Clinical Oncology. Humana Press, New Totowa, pp 397–419
Haskel S, Chen SS, Spiegel G (1989) Vaginal endometrioid adenocarcinoma arising in vaginal endometriosis: a case report and literature review. Gynecol Oncol 34(2):232–236. 0090-8258(89)90149-2[pii]
Hellman K, Lundell M, Silfversward C, Nilsson B, Hellstrom AC, Frankendal B (2006) Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer 16(3):1201–1211. doi:10.1111/j.1525-1438.2006.00520.x
Herbst AL, Robboy SJ, Scully RE, Poskanzer DC (1974) Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol 119(5):713–724
Hilaris BS, Nori D, Anderson LL (1987) Brachytherapy treatment planning. Front Radiat Ther Oncol 21:94–106
Hinchey WW, Silva EG, Guarda LA, Ordonez NG, Wharton JT (1983) Paravaginal wolffian duct (mesonephros) adenocarcinoma: a light and electron microscopic study. Am J Clin Pathol 80(4):539–544
Hintz BL, Kagan AR, Chan P, Gilbert HA, Nussbaum H, Rao AR, Wollin M (1980) Radiation tolerance of the vaginal mucosa. Int J Radiat Oncol Biol Phys 6(6):711–716. 0360-3016(80)90227-8[pii]
Hiroi H, Yasugi T, Matsumoto K, Fujii T, Watanabe T, Yoshikawa H, Taketani Y (2001) Mucinous adenocarcinoma arising in a neovagina using the sigmoid colon thirty years after operation: a case report. J Surg Oncol 77(1):61–64. doi:10.1002/jso.1067
Hoffman MS, Roberts WS, LaPolla JP, Fiorica JV, Cavanagh D (1991) Laser vaporization of grade 3 vaginal intraepithelial neoplasia. Am J Obstet Gynecol 165(5 Pt 1):1342–1344
Hoffman MS, DeCesare SL, Roberts WS, Fiorica JV, Finan MA, Cavanagh D (1992) Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina. Am J Obstet Gynecol 166(1 Pt 1):30–33
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249. doi:10.3322/caac.20006
Jobson VW, Homesley HD (1983) Treatment of vaginal intraepithelial neoplasia with the carbon dioxide laser. Obstet Gynecol 62(1):90–93
Julian TM, O’Connell BJ, Gosewehr JA (1992) Indications, techniques, and advantages of partial laser vaginectomy. Obstet Gynecol 80(1):140–143
Kaufman RH, Korhonen MO, Strama T, Adam E, Kaplan A (1982) Development of clear cell adenocarcinoma in DES-exposed offspring under observation. Obstet Gynecol 59(6 Suppl):68S–72S
Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, Walker JL, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340(15):1154–1161
Kirkbride P, Fyles A, Rawlings GA, Manchul L, Levin W, Murphy KJ, Simm J (1995) Carcinoma of the vagina–experience at the Princess Margaret Hospital (1974–1989). Gynecol Oncol 56(3):435–443. doi:10.1006/gyno.1995.1077
Krebs HB (1989) Treatment of vaginal intraepithelial neoplasia with laser and topical 5-fluorouracil. Obstet Gynecol 73(4):657–660
Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40(1):12–16
Kucera H, Mock U, Knocke TH, Kucera E, Potter R (2001) Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy. Acta Obstet Gynecol Scand 80(4):355–360. aog800412[pii]
Kushner DM, Fleming PA, Kennedy AW, Wilkinson DA, Lee E, Saffle PA (2003) High dose rate (192)Ir afterloading brachytherapy for cancer of the vagina. Br J Radiol 76(910):719–725
Lamoreaux WT, Grigsby PW, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA (2005) FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 62(3):733–737. doi:10.1016/j.ijrobp.2004.12.011
Lee WR, Marcus RB Jr, Sombeck MD, Mendenhall WM, Morgan LS, Freeman DE, Million RR (1994) Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time. Int J Radiat Oncol Biol Phys 29(5):983–988
Lenehan PM, Meffe F, Lickrish GM (1986) Vaginal intraepithelial neoplasia: biologic aspects and management. Obstet Gynecol 68(3):333–337
Leung S, Sexton M (1993) Radical radiation therapy for carcinoma of the vagina–impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970–1990. Int J Radiat Oncol Biol Phys 25(3):413–418
Li Z, Liu C, Palta JR (1998) Optimized dose distribution of a high dose rate vaginal cylinder. Int J Radiat Oncol Biol Phys 41(1):239–244. S0360-3016(98)00014-5[pii]
Lian J, Dundas G, Carlone M, Ghosh S, Pearcey R (2008) Twenty-year review of radiotherapy for vaginal cancer: an institutional experience. Gynecol Oncol 111(2):298–306. doi:10.1016/j.ygyno.2008.07.007
Maassen V, Lampe B, Untch M, Mikorey S, Hepp H, Kindermann G (1993) Adenocarcinoma and adenosis of the vagina. On the histogenesis, diagnosis and therapy of a rare genital neoplasms. Geburtshilfe Frauenheilkd 53(5):308–313. doi:10.1055/s-2007-1022888
MacLeod C, Fowler A, Dalrymple C, Atkinson K, Elliott P, Carter J (1997) High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina. Gynecol Oncol 65(1):74–77. doi:10.1006/gyno.1996.4608
MacNaught R, Symonds RP, Hole D, Watson ER (1986) Improved control of primary vaginal tumours by combined external-beam and interstitial radiotherapy. Clin Radiol 37(1):29–32. S0009-9260(86)80160-X[pii]
Magrina JF, Masterson BJ (1981) Vaginal reconstruction in gynecological oncology: a review of techniques. Obstet Gynecol Surv 36(1):1–10
Martinez A, Cox RS, Edmundson GK (1984) A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies. Int J Radiat Oncol Biol Phys 10(2):297–305. 0360-3016(84)90016-6[pii]
Menkarios C, Azria D, Laliberte B, Moscardo CL, Gourgou S, Lemanski C, Dubois JB, Ailleres N, Fenoglietto P (2007) Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 2:41. doi:10.1186/1748-717X-2-41
Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ (2005) Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63(2):354–361. doi:10.1016/j.ijrobp.2005.02.030
Mock U, Kucera H, Fellner C, Knocke TH, Potter R (2003) High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. Int J Radiat Oncol Biol Phys 56(4):950–957. S0360301603002177[pii]
Molla M, Escude L, Nouet P, Popowski Y, Hidalgo A, Rouzaud M, Linero D, Miralbell R (2005) Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy? Int J Radiat Oncol Biol Phys 62(1):118–124. doi:10.1016/j.ijrobp.2004.09.028
Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G (1998) Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42(1):79–85. S0360-3016(98)00193-X[pii]
Moran MS, Castrucci WA, Ahmad M, Song H, Lund MW, Mani S, Chamberlain D, Higgins SA (2010) Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes. Int J Radiat Oncol Biol Phys 76(4):1026–1036. doi:10.1016/j.ijrobp.2009.02.066
Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340(15):1137–1143
Munkarah A, Malone JM Jr, Budev HD, Evans TN (1994) Mucinous adenocarcinoma arising in a neovagina. Gynecol Oncol 52(2):272–275. doi:10.1006/gyno.1994.1045
Nanavati PJ, Fanning J, Hilgers RD, Hallstrom J, Crawford D (1993) High-dose-rate brachytherapy in primary stage I and II vaginal cancer. Gynecol Oncol 51(1):67–71. doi:10.1006/gyno.1993.1248
Ogino I, Kitamura T, Okajima H, Matsubara S (1998) High-dose-rate intracavitary brachytherapy in the management of cervical and vaginal intraepithelial neoplasia. Int J Radiat Oncol Biol Phys 40(4):881–887. S0360-3016(97)00924-3[pii]
Otton GR, Nicklin JL, Dickie GJ, Niedetzky P, Tripcony L, Perrin LC, Crandon AJ (2004) Early-stage vaginal carcinoma–an analysis of 70 patients. Int J Gynecol Cancer 14(2):304–310. doi:10.1111/j.1048-891X.2004.014214.x
Parikh JH, Barton DP, Ind TE, Sohaib SA (2008) MR imaging features of vaginal malignancies. Radiographics 28(1):49–63; quiz 322. doi:10.1148/rg.281075065
Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG (2010) intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2009.09.046
Perez CA, Arneson AN, Galakatos A, Samanth HK (1973) Malignant tumors of the vagina. Cancer 31(1):36–44
Perez CA, Korba A, Sharma S (1977) Dosimetric considerations in irradiation of carcinoma of the vagina. Int J Radiat Oncol Biol Phys 2(7–8):639–649
Perez CA, Camel HM, Galakatos AE, Grigsby PW, Kuske RR, Buchsbaum G, Hederman MA (1988) Definitive irradiation in carcinoma of the vagina: long-term evaluation of results. Int J Radiat Oncol Biol Phys 15(6):1283–1290
Perez CA, Slessinger E, Grigsby PW (1990) Design of an afterloading vaginal applicator (MIRALVA). Int J Radiat Oncol Biol Phys 18(6):1503–1508
Perez CA, Grigsby PW, Garipagaoglu M, Mutch DG, Lockett MA (1999) Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44(1):37–45. S0360-3016(98)00530-6[pii]
Peters WA 3rd, Kumar NB, Morley GW (1985) Carcinoma of the vagina. Factors influencing treatment outcome. Cancer 55(4):892–897
Petrilli ES, Townsend DE, Morrow CP, Nakao CY (1980) Vaginal intraepithelial neoplasia: biologic aspects and treatment with topical 5-fluorouracil and the carbon dioxide laser. Am J Obstet Gynecol 138(3):321–328
Pingley S, Shrivastava SK, Sarin R, Agarwal JP, Laskar S, Deshpande DD, Dinshaw KA (2000) Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys 46(1):101–108. S0360-3016(99)00360-0[pii]
Piver MS, Barlow JJ, Tsukada Y, Gamarra M, Sandecki A (1979) Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 percent 5-fluorouracil cream. Am J Obstet Gynecol 135(3):377–380. 0002-9378(79)90709-9[pii]
Plentl AA, Friedman EA (1971) Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol 2:1–223
Prempree T, Amornmarn R (1985) Radiation treatment of primary carcinoma of the vagina. Patterns of failures after definitive therapy. Acta Radiol Oncol 24(1):51–56
Puthawala A, Syed AM, Nalick R, McNamara C, DiSaia PJ (1983) Integrated external and interstitial radiation therapy for primary carcinoma of the vagina. Obstet Gynecol 62(3):367–372
Randall ME, Evans L, Greven KM, McCunniff AJ, Doline RM (1993) Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol 48(1):23–31. doi:10.1006/gyno.1993.1005
Reddy S, Saxena VS, Lee MS, Yordan EL, Graham JE, Phillips R, Hendrickson FR (1991) Results of radiotherapeutic management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 21(4):1041–1044. 0360-3016(91)90747-R[pii]
Reid GC, Schmidt RW, Roberts JA, Hopkins MP, Barrett RJ, Morley GW (1989) Primary melanoma of the vagina: a clinicopathologic analysis. Obstet Gynecol 74(2):190–199. 0029-7844(89)90057-4[pii]
Riva C, Fabbri A, Facco C, Tibiletti MG, Guglielmin P, Capella C (1997) Primary serous papillary adenocarcinoma of the vagina: a case report. Int J Gynecol Pathol 16(3):286–290
Robboy SJ, Herbst AL, Scully RE (1974) Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer 34(3):606–614
Robboy SJ, Scully RE, Welch WR, Herbst AL (1977) Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med 101(1):1–5
Robboy SJ, Welch WR, Young RH, Truslow GY, Herbst AL, Scully RE (1982) Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol 60(5):546–551
Robboy SJ, Young RH, Welch WR, Truslow GY, Prat J, Herbst AL, Scully RE (1984) Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer 54(5):869–875
Roberts WS, Hoffman MS, Kavanagh JJ, Fiorica JV, Greenberg H, Finan MA, Cavanagh D (1991) Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecol Oncol 43(3):233–236
Robinson JB, Sun CC, Bodurka-Bevers D, Im DD, Rosenshein NB (2000) Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia. Gynecol Oncol 78(2):235–241. doi:10.1006/gyno.2000.5881
Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340(15):1144–1153
Rubin P, Casarett GW (1968) Clinical radiation pathology, vol 2. W. B. Saunders, Philadelphia
Rubin SC, Young J, Mikuta JJ (1985) Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up. Gynecol Oncol 20(3):346–353. 0090-8258(85)90216-1[pii]
Russell AH, Koh WJ, Markette K, Russell KJ, Cain JM, Tamimi HK, Greer BE, Figge DC (1987) Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tract. Gynecol Oncol 27(2):226–232. 0090-8258(87)90297-6[pii]
Rutkowski T, Bialas B, Rembielak A, Fijalkowski M, Nowakowski K (2002) Efficacy and toxicity of MDR versus HDR brachytherapy for primary vaginal cancer. Neoplasma 49(3):197–200
Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ (2007) Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 25(29):4581–4586. doi:10.1200/JCO.2007.12.0170
Samant R, Lau B, E C, Le T, Tam T (2007) Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum. Int J Radiat Oncol Biol Phys 69(3):746–750
Sedlis AR, Robboy SJ (1987) Diseases of the vagina. In: Kurman RJ (ed) Blaustein’s Pathology of the Female Genital Tract, 3rd edn. Springer Verlag, New York
Shah CA, Goff BA, Lowe K, Peters WA III, Li CI (2009) Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol 113(5):1038–1045. doi:10.1097/AOG.0b013e31819fe844
Shah AP, Strauss JB, Gielda BT, Zusag TW (2010) Toxicity associated with bowel or bladder puncture during gynecologic interstitial brachytherapy. Int J Radiat Oncol Biol Phys 77(1):171–179. doi:10.1016/j.ijrobp.2009.04.077
Sinha B, Stehman F, Schilder J, Clark L, Cardenes H (2009) Indiana University experience in the management of vaginal cancer. Int J Gynecol Cancer 19(4):686–693. doi:10.1111/IGC.0b013e3181a12e1d
Spanos W Jr, Guse C, Perez C, Grigsby P, Doggett RL, Poulter C (1989) Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502. Int J Radiat Oncol Biol Phys 17(3):659–661
Spanos WJ Jr, Perez CA, Marcus S, Poulter CA, Doggett RL, Steinfeld AD, Grigsby PW (1993) Effect of rest interval on tumor and normal tissue response–a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502). Int J Radiat Oncol Biol Phys 25(3):399–403
Spanos WJ Jr, Clery M, Perez CA, Grigsby PW, Doggett RL, Poulter CA, Steinfeld AD (1994) Late effect of multiple daily fraction palliation schedule for advanced pelvic malignancies (RTOG 8502). Int J Radiat Oncol Biol Phys 29(5):961–967
Stafl A, Wilkinson EJ, Mattingly RF (1977) Laser treatment of cervical and vaginal neoplasia. Am J Obstet Gynecol 128(2):128–136
Stock RG, Mychalczak B, Armstrong JG, Curtin JP, Harrison LB (1992) The importance of brachytherapy technique in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 24(4):747–753
Stock RG, Chen AS, Seski J (1995) A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol 56(1):45–52. doi:10.1006/gyno.1995.1008
Stock RG, Chan K, Terk M, Dewyngaert JK, Stone NN, Dottino P (1997) A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance. Int J Radiat Oncol Biol Phys 37(4):819–825. S0360-3016(96)00558-5[pii]
Sun SS, Chen TC, Yen RF, Shen YY, Changlai SP, Kao A (2001) Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Anticancer Res 21(4B):2957–2961
Syed AMN, Puthawala AA, Neblett DL, Disaia PJ, Berman ML, Rettenmaier M, Nalick R, McNamara C (1987) Transperineal interstitial-intracavitary “Syed-Neblett” applicator in the treatment of carcinoma of the uterine cervix. Endocurietherapy/Hyperthermia Oncol 2:1–13
Tabata T, Takeshima N, Nishida H, Hirai Y, Hasumi K (2002) Treatment failure in vaginal cancer. Gynecol Oncol 84(2):309–314. doi:10.1006/gyno.2001.6520
Tarraza MH Jr, Muntz H, Decain M, Granai OC, Fuller A Jr (1991) Patterns of recurrence of primary carcinoma of the vagina. Eur J Gynaecol Oncol 12(2):89–92
Tavassoli FA, Norris HJ (1979) Smooth muscle tumors of the vagina. Obstet Gynecol 53(6):689–693
Taylor MB, Dugar N, Davidson SE, Carrington BM (2007) Magnetic resonance imaging of primary vaginal carcinoma. Clin Radiol 62(6):549–555. doi:10.1016/j.crad.2007.01.008
Tjalma WA, Monaghan JM, de Barros Lopes A, Naik R, Nordin AJ, Weyler JJ (2001) The role of surgery in invasive squamous carcinoma of the vagina. Gynecol Oncol 81(3):360–365. doi:10.1006/gyno.2001.6171
Townsend DE, Levine RU, Crum CP, Richart RM (1982) Treatment of vaginal carcinoma in situ with the carbon dioxide laser. Am J Obstet Gynecol 143(5):565–568. 0002-9378(82)90548-8[pii]
Tran PT, Su Z, Lee P, Lavori P, Husain A, Teng N, Kapp DS (2007) Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Gynecol Oncol 105(3):641–649. doi:10.1016/j.ygyno.2007.01.033
Tyree WC, Cardenes H, Randall M, Papiez L (2002) High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications. Int J Gynecol Cancer 12(1):27–31
Urbanski K, Kojs Z, Reinfuss M, Fabisiak W (1996) Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60(1):16–21. doi:10.1006/gyno.1996.0004
Van der Zee J, Kleynen CE, Nuyttens JJ, Ansink AC (2008) Hyperthermia to improve results in vaginal cancer. Radiother Oncol 88(2):286–287. doi:10.1016/j.radonc.2008.01.020
Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL, Liao SY (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17(5):1339–1348
Woodruff JD, Parmley TH, Julian CG (1975) Topical 5-fluorouracil in the treatment of vaginal carcinoma-in situ. Gynecol Oncol 3(2):124–132
Xiang EW, Shu-mo C, Ya-qin D, Ke W (1998) Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases. Gynecol Oncol 69(2):125–129. doi:10.1006/gyno.1998.4975
Zaino RJ, Robboy SJ, Kurman RJ (2002) Diseases of the vagina. In: Kurman RJ (ed) Blaustein’s Pathology of the Female Genital Tract, 5th edn edn. Springer Verlag, New York, pp 151–206
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cardenes, H.R., Zook, J.E., Andolino, D.L. (2011). Carcinoma of the Vagina. In: Levitt, S., Purdy, J., Perez, C., Poortmans, P. (eds) Technical Basis of Radiation Therapy. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_157
Download citation
DOI: https://doi.org/10.1007/174_2011_157
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11571-4
Online ISBN: 978-3-642-11572-1
eBook Packages: MedicineMedicine (R0)